rs2235751
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_024411.5(PDYN):c.-20+3296T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.4 in 151,976 control chromosomes in the GnomAD database, including 14,937 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.40 ( 14937 hom., cov: 32)
Consequence
PDYN
NM_024411.5 intron
NM_024411.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.883
Publications
19 publications found
Genes affected
PDYN (HGNC:8820): (prodynorphin) The protein encoded by this gene is a preproprotein that is proteolytically processed to form the secreted opioid peptides beta-neoendorphin, dynorphin, leu-enkephalin, rimorphin, and leumorphin. These peptides are ligands for the kappa-type of opioid receptor. Dynorphin is involved in modulating responses to several psychoactive substances, including cocaine. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.82 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.400 AC: 60692AN: 151858Hom.: 14918 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
60692
AN:
151858
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.400 AC: 60773AN: 151976Hom.: 14937 Cov.: 32 AF XY: 0.404 AC XY: 29990AN XY: 74286 show subpopulations
GnomAD4 genome
AF:
AC:
60773
AN:
151976
Hom.:
Cov.:
32
AF XY:
AC XY:
29990
AN XY:
74286
show subpopulations
African (AFR)
AF:
AC:
27051
AN:
41436
American (AMR)
AF:
AC:
5078
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
925
AN:
3472
East Asian (EAS)
AF:
AC:
4340
AN:
5160
South Asian (SAS)
AF:
AC:
2347
AN:
4812
European-Finnish (FIN)
AF:
AC:
3093
AN:
10570
Middle Eastern (MID)
AF:
AC:
92
AN:
294
European-Non Finnish (NFE)
AF:
AC:
16832
AN:
67948
Other (OTH)
AF:
AC:
752
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1577
3154
4730
6307
7884
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2400
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.